Cargando…
Age-Dependent Anti-migraine Effects of Valproic Acid and Topiramate in Rats
Background: Valproic acid (VPA) and topiramate (TPM), initially developed as antiepileptics, are approved for migraine prophylaxis in adults but not children. The differences in their antimigraine mechanism(s) by age remain unclear. Methods: A migraine model induced by intra-cisternal (i.c.) capsaic...
Autores principales: | Huang, Pokai, Kuo, Ping-Hung, Lee, Ming Tatt, Chiou, Lih-Chu, Fan, Pi-Chuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167431/ https://www.ncbi.nlm.nih.gov/pubmed/30319425 http://dx.doi.org/10.3389/fphar.2018.01095 |
Ejemplares similares
-
Plasma Calcitonin Gene-Related Peptide: A Potential Biomarker for Diagnosis and Therapeutic Responses in Pediatric Migraine
por: Fan, Pi-Chuan, et al.
Publicado: (2019) -
Fremanezumab in individuals with chronic migraine who had inadequate response to onabotulinumtoxinA and topiramate or valproic acid
por: Ferrari, Michel D., et al.
Publicado: (2022) -
Advances in topiramate as prophylactic treatment for migraine
por: Hu, Chuan, et al.
Publicado: (2021) -
Topiramate in migraine progression
por: Ruiz, Luigi, et al.
Publicado: (2009) -
Hyperammonemic Encephalopathy due to Valproic Acid and Topiramate Interaction
por: Twilla, Jennifer D., et al.
Publicado: (2014)